These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 15821244

  • 1. Pathological and clinical response of a primary chemotherapy regimen combining vinorelbine, epirubicin, and paclitaxel as neoadjuvant treatment in patients with operable breast cancer.
    Abrial C, Van Praagh I, Delva R, Leduc B, Fleury J, Gamelin E, Sillet-Bach I, Penault-Llorca F, Amat S, Chollet P.
    Oncologist; 2005 Apr; 10(4):242-9. PubMed ID: 15821244
    [Abstract] [Full Text] [Related]

  • 2. Paclitaxel combinations as front-line and salvage chemotherapy regimens in advanced breast cancer.
    Conte PF, Baldini E, Michelotti A, Salvadori B, Gennari A, Da Prato M, Tibaldi C, Giannessi PG, Gentile A.
    Semin Oncol; 1996 Dec; 23(6 Suppl 15):39-42. PubMed ID: 8996597
    [Abstract] [Full Text] [Related]

  • 3. Multidisciplinary therapy of locally far-advanced or inflammatory breast cancer with fixed perioperative sequence of epirubicin, vinorelbine, and Fluorouracil chemotherapy, surgery, and radiotherapy: long-term results.
    Ardavanis A, Scorilas A, Tryfonopoulos D, Orphanos G, Missitzis I, Karamouzis M, Chrysochoou M, Sotiropoulou A, Arnogiannaki N, Ioannidis G, Pissakas G, Rigatos G.
    Oncologist; 2006 Jun; 11(6):563-73. PubMed ID: 16794236
    [Abstract] [Full Text] [Related]

  • 4. Weekly paclitaxel with epirubicin as second-line therapy of metastatic breast cancer: results of a clinical phase II study.
    Köhler U, Olbricht SS, Fuechsel G, Kettner E, Richter B, Ridwelski K.
    Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-40-S17-43. PubMed ID: 9374091
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. 5-year results of cisplatin-epirubicin-vinorelbine (PEV) combination as primary chemotherapy in T2-3, N0-2 breast cancer patients: a multicentre phase II study.
    Barni S, Visini M, Piazza E, Ionta MT, Ardizzoia A, Arnoldi E, Fava S, Pinotti G, Torretta F, Corradini G, Villa S, Nosenzo AM, Massidda B, Cazzaniga ME.
    Anticancer Res; 2007 Oct; 27(4C):3019-24. PubMed ID: 17695490
    [Abstract] [Full Text] [Related]

  • 9. Neoadjuvant chemotherapy with vinorelbine-containing regimens in elderly patients with locally advanced breast cancer.
    Ma CD, Chen CM, Chen XS, Liu GY, Di GH, Wu J, Lu JS, Yang WT, Chen JY, Shao ZM, Shen ZZ, Shen KW.
    Anticancer Res; 2008 Oct; 28(5B):3093-7. PubMed ID: 19031963
    [Abstract] [Full Text] [Related]

  • 10. Pilot study of vinorelbine (Navelbine) and paclitaxel (Taxol) in patients with refractory breast cancer and lung cancer.
    Chang AY, Garrow GC.
    Semin Oncol; 1995 Apr; 22(2 Suppl 5):66-70; discussion 70-1. PubMed ID: 7740336
    [Abstract] [Full Text] [Related]

  • 11. Phase I/II clinical trial of epirubicin and paclitaxel followed by granulocyte colony-stimulating factor in a 2-week schedule in patients with advanced or metastatic breast cancer.
    Ries F, Duhem C, Kleiber K, Dicato M.
    Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-48-S17-51. PubMed ID: 9374093
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Neoadjuvant treatment of locally advanced carcinoma of the uterine cervix with epirubicin, paclitaxel and cisplatin.
    D'Agostino G, Distefano M, Greggi S, Salerno M, Ferrandina G, Poerio A, Mancuso S, Scambia G.
    Cancer Chemother Pharmacol; 2002 Mar; 49(3):256-60. PubMed ID: 11935219
    [Abstract] [Full Text] [Related]

  • 14. First-line chemotherapy with fluorouracil-epirubicin-navelbine (FEN) combination in advanced breast cancer.
    Ardavanis A, Tryfonopoulos D, Orphanos G, Ioannidis G, Karamouzis M, Rigatos G.
    Anticancer Res; 2005 Mar; 25(6C):4493-8. PubMed ID: 16334132
    [Abstract] [Full Text] [Related]

  • 15. Concomitant versus sequential administration of epirubicin and paclitaxel as first-line therapy in metastatic breast carcinoma: results for the Gruppo Oncologico Nord Ovest randomized trial.
    Conte PF, Guarneri V, Bruzzi P, Prochilo T, Salvadori B, Bolognesi A, Aldrighetti D, Venturini M, Rosso R, Mammoliti S, Carnino F, Giannessi P, Costantini M, Moyano A, Baldini E, Gruppo Oncologico Nord Ovest.
    Cancer; 2004 Aug 15; 101(4):704-12. PubMed ID: 15305399
    [Abstract] [Full Text] [Related]

  • 16. Pilot study of primary chemotherapy with doxorubicin plus paclitaxel in women with locally advanced or operable breast cancer.
    Moliterni A, Tarenzi E, Capri G, Terenziani M, Bertuzzi A, Grasselli G, Agresti R, Piotti P, Greco M, Salvadori B, Pilotti S, Lombardi F, Valagussa P, Bonadonna G, Gianni L.
    Semin Oncol; 1997 Oct 15; 24(5 Suppl 17):S17-10-S17-14. PubMed ID: 9374085
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Neoadjuvant chemotherapy with docetaxel plus epirubicin for locally advanced breast cancer: a multi-center phase II study].
    Shen ZZ, Liu GY, Su FX, He PQ, Yang MT, Shi JY, Sheng Y, Zou Q, Li YF.
    Zhonghua Zhong Liu Za Zhi; 2005 Feb 15; 27(2):126-8. PubMed ID: 15946557
    [Abstract] [Full Text] [Related]

  • 19. Alternating intravenous and oral vinorelbine plus epirubicin with pegfilgrastim as neoadjuvant treatment of locally advanced breast cancer.
    Livi L, Paiar F, Santini R, De Luca Cardillo C, Galardi A, Di Cosmo D, Borghesi S, Agresti B, Nosi F, Gavilli S, Biti GP.
    Anticancer Drugs; 2006 Oct 15; 17(9):1081-5. PubMed ID: 17001182
    [Abstract] [Full Text] [Related]

  • 20. Weekly epirubicin and paclitaxel with granulocyte colony-stimulating factor support in previously untreated metastatic breast cancer patients: a phase II study.
    Nisticò C, Bria E, Cuppone F, Fornier M, Sperduti I, Carpino A, Pace A, Cognetti F, Terzoli E.
    Anticancer Drugs; 2007 Jul 15; 18(6):687-92. PubMed ID: 17762397
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.